GlassScriptPhysician profile
Babak Kaviani
NPI 1962698241
$1,704.83
in general payments reported to CMS, 2019-2025
23 companies · $378 in 2025
The $378 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $28.43 · 2021: $135 · 2022: $285 · 2023: $319 · 2024: $293 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $990.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $989.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $257.89 | 2019-2024 | Citrefix, Cartiva Synthetic Cartilage Implant, Inspace |
| Integra Lifesciences Corporation | $239.96 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Abbvie INC. | $189.40 | 2021-2025 | |
| Abbott Laboratories | $128.70 | 2023-2025 | Octrode, Proclaim |
| Treace Medical Concepts, INC. | $117.42 | 2022-2025 | |
| Mimedx Group, INC. | $105.43 | 2025 | |
| Bone Support INC. | $101.35 | 2025 | Cerament G, Ceramentbone Void Filler |
| Orthofix Medical, INC. | $81.28 | 2019-2023 | Physio-Stim, Spinal-Stim |
| Smith+Nephew, INC. | $61.39 | 2021-2022 | |
| Wright Medical Technology, INC. | $54.56 | 2019 | |
| Organogenesis INC. | $52.40 | 2024 | Affinity |
| Depuy Synthes Sales INC. | $46.07 | 2024 | |
| Misonix INC | $38.39 | 2019 | |
| Bioventus LLC | $35.73 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $35.20 | 2021-2023 | Krystexxa |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $32.00 | 2023 | |
| Biocomposites INC | $21.92 | 2025 | Stimulan |
| Access Pro Medical, LLC | $21.46 | 2023 | Matriderm |
| Baudax Bio INC. | $20.09 | 2021 | |
| Nevro Corp. | $19.80 | 2022 | |
| Heron Therapeutics, INC. | $18.06 | 2021 | |
| Medtronic, INC. | $13.87 | 2024 | Intellis Adaptivestim |
| Arteriocyte Medical Systems, INC. | $12.46 | 2023 | Magellan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Babak Kaviani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.